Research libraryMOLEKUL / SOURCE RECORD

[Cortexin in the comprehensive treatment of neurological complications of type 2 diabetes mellitus. (Results of the DIACORT multicenter randomized clinical trial)].

Authors not supplied in indexed record · 2026 · Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova; 2026

Randomized trialEnglish abstractSource linked
This is Molekul’s research summary, not the original publication. Educational information only, not medical advice. Seek qualified healthcare help for medical conditions.

Study findings

The DIACORT study reported greater improvements in cognition, anxiety/depression and neuropathy measures when Cortexin was added to glycine and B vitamins, with follow-up through day 90.

Population and setting
110 patients with neurological complications of type 2 diabetes; 55 per group
Evidence type
Randomized trial
Preparation
See the original report; formulation details require verification.
Source language
rus
Title source
Title as recorded in the linked source or index. A separate original-language title has not been transcribed unless shown above.

Study limitations

  • Adjunctive treatment; not evidence for Cortexin alone.
  • Masking, allocation concealment and handling of multiple outcomes require full-methods review.
  • Five adverse events were reported across both groups; the sample and duration cannot establish rare or long-term safety.

Publication counts are not counts of independent trials. Reviews, translations and reports sharing participants may overlap. Findings apply to the studied preparation, population and endpoints.

Source access and review scope

Indexed record and abstract checked. Full methods and risk of bias have not been independently assessed.

Recorded source-check date: 2026-10-06. This date does not imply a completed systematic review.

Open original source or index record ↗

DOI: 10.17116/jnevro2026126041101

Citation and original source

Original source: Authors not supplied in indexed record. [Cortexin in the comprehensive treatment of neurological complications of type 2 diabetes mellitus. (Results of the DIACORT multicenter randomized clinical trial)]. Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova; 2026 2026.

Molekul research summary: https://molekul.io/research/recent-42133422. Cite the original publication for its findings and this page when referring to Molekul’s summary or evidence appraisal.

Bibliography entry

Related compound profiles

Editorial policy and evidence standards